Abdominal Pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal pigmentation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal renal function
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of skin morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the pons
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absence of septum pellucidum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absent speech
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Adenocarcinoma Of Esophagus
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The Phosphatidylinositol glycan class A (PIG-A) gene mutation assay phenotypically measures erythrocyte mutations, assessed here for their correlation to neoplastic progression in the gastro-oesophageal reflux disease (GORD)-Barrett's metaplasia (BM)-oesophageal adenocarcinoma (OAC) model.
|
30914682 |
2019 |
Adult Burkitt Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
GPI-anchored protein deficiency in Burkitt lymphoma cells is not due to a genetic mutation (e.g., PIGA); rather, the lack of GPI-anchored proteins results from transcriptional silencing of PIGL and PIGY.
|
19302917 |
2009 |
Agenesis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Somatic PIG-A mutations could arise after aplasia, or healthy persons could have rare PIG-A mutant cells that expand under selection pressure.
|
11750098 |
2001 |
Anemia, Hemolytic
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anemia, Hemolytic, Acquired
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Paroxysmal nocturnal hemoglobinuria is an acquired hemolytic anemia associated with somatic mutations in the X-linked gene PIG-A, which encodes a protein involved in the biosynthesis of glycosyl phosphatidylinositol anchors.
|
8541557 |
1995 |
Anemia, Hemolytic, Acquired
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia caused by the expansion of a hematopoietic progenitor cell that has acquired a mutation in the X-linked PIGA gene.
|
19074066 |
2008 |
Anemia, Hemolytic, Acquired
|
0.030 |
Biomarker
|
disease |
BEFREE |
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia that is characterized by a deficiency of glycosylphosphatidylinositol-anchored membrane proteins due to phosphatidylinositol glycan-class A (PIG-A) gene abnormalities in various lineages of peripheral blood cells and hematopoietic precursors.
|
11301179 |
2001 |
Angina Pectoris
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anteverted nostril
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
19 patients (51%) had aplastic anaemia; their PIG-A mutations were not different from those without pre-existing aplastic anaemia.
|
10233427 |
1999 |
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Acute myelogenous leukemia with PIG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome.
|
11372733 |
2001 |
Aplastic Anemia
|
0.200 |
Biomarker
|
disease |
BEFREE |
This theory is supported by clinical observation indicating that PIG-A mutant cells survive immune-mediated bone marrow injury in patients with aplastic anemia, PNH, and myelodysplastic syndromes.
|
12627846 |
2003 |
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The most frequent base or type abnormalities of the PIG-A gene in AA and MDS patients were base substitutions or missense mutations, respectively, and deletions or frameshift mutations, respectively, in PNH patients.
|
16467865 |
2006 |
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
We have studied a large series of AA patients with a GPI anchor-deficient clone (AA/PNH), including patients with minor clones, to determine whether their pattern of PIG-A mutations was identical to the reported spectrum in hemolytic PNH.
|
12424196 |
2003 |
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We suggest that the somatic PIG-A gene mutations highlight a subgroup of AA having a pathogenetic link with PNH.
|
9163589 |
1997 |
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
LHGDN |
This review examines the clinical and biological relevance of PIG-A mutations in PNH, aplastic anemia and healthy controls.
|
16923549 |
2006 |
Aplastic Anemia
|
0.200 |
Biomarker
|
disease |
BEFREE |
CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia.
|
10086790 |
1999 |
Aplastic Anemia
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
We have studied a large series of AA patients with a GPI anchor-deficient clone (AA/PNH), including patients with minor clones, to determine whether their pattern of PIG-A mutations was identical to the reported spectrum in hemolytic PNH.
|
12424196 |
2003 |